Regenxbio RGNX
NASDAQ RGNX
$7.43 +0.01 (+0.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Cash from Investing Activities (2015 - 2025)

Updated

Regenxbio's Cash from Investing Activities was $37.54 million in Q4 2025, down 6.8% from $40.27 million a year earlier and down 11.2% from the prior quarter.

Analysis

Regenxbio (RGNX) Cash from Investing Activities (2015 - 2025) Analysis & Trends

For FY2025, Cash from Investing Activities at Regenxbio came in at -$15.87 million.

  • In earlier years, Cash from Investing Activities was $103.45 million in FY2024 (-45.8%), $190.94 million in FY2023, -$11.93 million in FY2022 and -$406.64 million in FY2021.
  • Quarterly Cash from Investing Activities has moved between -$216.36 million (Q4 2021) and $63.09 million (Q1 2023) over five years.
  • Compared with a year earlier, Cash from Investing Activities was higher in three of the last six quarters, with growth averaging 31.0%.
  • The best year-over-year quarter for Cash from Investing Activities over five years was Q1 2025 (growth of 239.4%); the worst was Q2 2021 (a decline of 82.5%).
  • Per Business Quant data, RGNX's Cash from Investing Activities in the three quarters before Q4 2025 was $42.29 million (Q3 2025), -$140.44 million (Q2 2025) and $44.74 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Regenxbio 402.44 Mn -530.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 37.54 Mn
Sep 30, 2025 42.29 Mn
Jun 30, 2025 -140.44 Mn
Mar 31, 2025 44.74 Mn
Dec 31, 2024 40.27 Mn
Sep 30, 2024 50.26 Mn
Jun 30, 2024 -268,000.00
Mar 31, 2024 13.18 Mn
Dec 31, 2023 33.97 Mn
Sep 30, 2023 38.66 Mn
Jun 30, 2023 55.22 Mn
Mar 31, 2023 63.09 Mn
Dec 31, 2022 26.70 Mn
Sep 30, 2022 53.04 Mn
Jun 30, 2022 -1.08 Mn
Mar 31, 2022 -90.59 Mn
Dec 31, 2021 -216.36 Mn
Sep 30, 2021 16.10 Mn
Jun 30, 2021 7.80 Mn
Mar 31, 2021 -214.18 Mn
API Access

Regenxbio Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RGNX&period=max&api_key=YOUR_API_KEY